2025-09-28 - Analysis Report
Okay, let's break down the analysis of Natera Inc. (NTRA).

**Report on Natera Inc. (NTRA)**

**0. Overview**

This report provides an analysis of Natera Inc. (NTRA), focusing on its stock performance, financial health, and market sentiment. The analysis includes a comparison with the S&P 500 (VOO), technical indicators, analyst opinions, recent news, and earnings data.

Natera Inc. (NTRA) is a genetic testing company focused on non-invasive prenatal testing (NIPT) and cancer diagnostics.

**1. Performance vs. S&P 500 (VOO)**

*   **NTRA Cumulative Return:** 60.59%
*   **VOO Cumulative Return:** 66.41%
*   **Deviation (NTRA - VOO):** -5.82% (NTRA underperformed VOO)
*   **Relative Deviation:** 26.6 (NTRA's performance is in the lower range of its historical deviation from VOO).
*   **Deviation Range:** Max 127.4, Min -81.2, Current: -25.8
*   **Analysis Table:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | -11.0%  | 67.7%   | -21.0%  | -0.1  | 1.2    |
| 2016-2018  | 13.0%   | 71.0%   | 15.0%   | -0.1  | 1.9    |
| 2017-2019  | 47.0%   | 72.6%   | 43.0%   | 0.1   | 4.6    |
| 2018-2020  | 178.0%  | 80.5%   | 153.0%  | 0.2   | 13.7   |
| 2019-2021  | 97.0%   | 80.5%   | 68.0%   | 0.9   | 12.8   |
| 2020-2022  | -63.0%  | 80.5%   | -77.0%  | 0.6   | 5.5    |
| 2021-2023  | -171.0% | 76.7%   | -189.0% | -1.2  | 8.6    |
| 2022-2024  | -8.0%   | 76.7%   | -21.0%  | -1.2  | 21.7   |
| 2023-2025  | 79.0%   | 76.7%   | 44.0%   | -0.3  | 22.4   |

**Analysis:**

*   NTRA has shown periods of significant outperformance (e.g., 2018-2020) but also periods of significant underperformance (e.g., 2021-2023).
*   The negative Alpha values indicate that NTRA has generally underperformed its benchmark (VOO) on a risk-adjusted basis.
*   The Beta values are volatile, suggesting that NTRA's price is more sensitive to market movements and less predictable, and recently it has a negative correlation with the market.
*   High MDD (Maximum Drawdown) values indicate significant potential for losses.

**2. Recent Stock Price Movements**

*   **Current Price:** 162.97
*   **Previous Close:** 163.66
*   **Change:** -0.42
*   **5-day Moving Average:** 167.48
*   **20-day Moving Average:** 170.82
*   **60-day Moving Average:** 157.89

**Analysis:**

*   The current price is slightly lower than the previous close, indicating a slight downward trend.
*   The 5-day and 20-day moving averages are above the current price, suggesting a short-term downtrend.
*   The 60-day moving average is below the current price, suggesting that the longer-term trend might be more stable or slightly positive.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (Medium to High Investment Recommended)
*   **RSI:** 46.03 (Neutral - not overbought or oversold)
*   **PPO:** -1.20 (Negative, indicating a potential downtrend)
*   **Hybrid Signal:** Cash 0%, Buy 100% of cash (Very Safe) - Suggests a strong buy signal based on the algorithm.
*   **Delta_Previous_Relative_Divergence:** -3.6 (Short-term decrease in relative performance)
*   **Expected Return:** -137.4% (Negative, suggesting significant underperformance relative to the S&P 500 over a long-term investment horizon)
*   **Change:** -0.42 (Slightly negative, which does not point to a dramatic intraday movement)

**Analysis:**

*   MRI suggests a moderate to high level of investment appropriateness.
*   RSI is neutral.
*   PPO indicates a downward trend.
*   The Hybrid Signal suggests a strong buy.
*   Delta_Previous_Relative_Divergence confirms a recent short-term decline.
*   The significantly negative expected return is a major concern, suggesting potential underperformance relative to the S&P 500.

**4. Recent News & Significant Events**

*   **Negative News:** Multiple articles highlight reasons for NTRA stock being down on specific days.
*   **Insider Selling:** A significant insider sale of shares worth $9,016,668 could create negative sentiment.
*   **Potential Undervaluation:** One article suggests NTRA might be trading below estimated value.
*   **Overall:** The recent news flow is mixed, with some concerning signals.

**4-2. Analyst Opinions**

*   **Consensus:** Strong Buy
*   **Mean Rating:** 1.50 (Buy)
*   **Number of Opinions:** 20
*   **Target Price:**
    *   **Average:** 193.80
    *   **High:** 235.00
    *   **Low:** 37.00

**Analysis:**

*   Analysts generally have a positive outlook on NTRA, with a "Strong Buy" consensus and a mean rating of 1.50.
*   The average target price suggests significant upside potential. However, the wide range between the high and low target prices indicates uncertainty.
*   Lack of specific recent rating changes makes it difficult to assess current sentiment shifts.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue    |
| :----------- | :---- | :--------- |
| 2025-08-08 | -0.74 | 0.55 B$    |
| 2025-05-09 | -0.5  | 0.50 B$    |
| 2024-11-12 | -0.26 | 0.44 B$    |
| 2024-08-09 | -0.3  | 0.41 B$    |
| 2025-08-08 | -0.3  | 0.41 B$    |

**Analysis:**

*   Natera has consistently reported negative EPS, indicating ongoing losses.
*   Revenue has generally been increasing, suggesting growth in sales.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| :----------- | :------ | :------------ |
| 2025-06-30 | $0.55B | 63.41%        |
| 2025-03-31 | $0.50B | 63.12%        |
| 2024-12-31 | $0.48B | 62.94%        |
| 2024-09-30 | $0.44B | 61.79%        |
| 2024-06-30 | $0.41B | 58.83%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE       |
| :----------- | :------- | :-------- |
| 2025-06-30 | $1.25B  | -8.10%   |
| 2025-03-31 | $1.24B  | -5.40%   |
| 2024-12-31 | $1.20B  | -4.50%   |
| 2024-09-30 | $0.88B  | -3.60%   |
| 2024-06-30 | $0.84B  | -4.48%   |

**Analysis:**

*   Revenue has been steadily increasing, indicating positive business growth.
*   Profit margins are relatively high and increasing, suggesting good operational efficiency.
*   Equity is growing, indicating a strengthening financial position.
*   Negative ROE (Return on Equity) values reflect the company's ongoing losses relative to its equity.

**7. 종합 Analysis**

*   **Mixed Signals:** NTRA presents a complex picture. While analysts are generally positive and revenue/profit margins are improving, the company's stock has underperformed the S&P 500 and has a significantly negative expected return over the long term. Recent news is mixed, and insider selling raises concerns. The negative ROE and EPS values also indicate ongoing losses.
*   **Risk:** NTRA's high MDD and volatile Beta suggest a high-risk investment.
*   **Potential Upside:** Analyst target prices suggest potential upside if the company can execute its growth strategy and improve profitability.
*   **Recommendation:** Given the mixed signals and high risk, investors should exercise caution and carefully consider their risk tolerance before investing in NTRA. It may be prudent to wait for more consistent positive financial performance and a more stable market environment.
